High-Potency Oral Solid Dose & Softgel CDMO
Eirgen Pharma partners with global pharmaceutical and animal health companies to develop and manufacture complex small-molecule medicines. Our expertise spans highly potent and non-potent oral solid doses, softgel capsules, and veterinary pharmaceuticals, supported by advanced containment manufacturing and regulatory excellence.
A Specialist CDMO for Complex OSD Medicines
Eirgen Pharma is a research-driven contract development and manufacturing organization specializing in non-biologic small-molecule pharmaceuticals. From early development through commercial manufacturing, we support pharmaceutical and animal health companies with complex oral solid dose and softgel projects.
​
Our integrated facility in Waterford, Ireland combines scientific expertise, engineering capability, and advanced containment manufacturing to support the development and supply of medicines across global markets.
​
With a strong regulatory track record and a focus on partnership, we work closely with our clients to transform complex formulations into reliable commercial products.
​Why Choose Eirgen Pharma?
Innovation
Operational Excellence
Versatility
Compliance Assured
Our Core Capabilities
We deliver integrated development and manufacturing for oral solid doses, softgels, and high-potency compounds across human and animal health. Our approach combines advanced containment facilities, regulatory expertise, and decades of experience to deliver reliable, high-quality services from development through commercial supply.
